Skip Navigation

Cardiovascular Research 2004 61(4):671-682; doi:10.1016/j.cardiores.2003.11.038
© 2004 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Monaco, C.
Right arrow Articles by Paleolog, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Monaco, C.
Right arrow Articles by Paleolog, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004, European Society of Cardiology

Nuclear factor {kappa}B: a potential therapeutic target in atherosclerosis and thrombosis

Claudia Monaco and Ewa Paleolog*

Faculty of Medicine, Kennedy Institute of Rheumatology, Imperial College, Arthritis Research Campaign Building, 1, Aspenlea Road, London W6 8LH, UK

* Corresponding author. Tel.: +44-20-8383-4481; fax: +44-20-8383-4499. e.paleolog{at}imperial.ac.uk

Cardiovascular diseases are the leading cause of morbidity and mortality in Western countries. Atherosclerosis, the background for many cardiovascular diseases, is characterized by the accumulation of lipid and fibrotic entities in large arteries and bears many similarities with chronic inflammatory diseases such as rheumatoid arthritis. Common features include extravasation of blood-derived leukocytes, as well as production of cytokines, chemokines and matrix-degrading enzymes. There are also many shared signaling pathways, including activation of the nuclear factor {kappa}B (NF{kappa}B) cascade. In the context of atherosclerosis, there are a range of candidate stimuli which can activate NF{kappa}B, including traditional risk factors, infectious agents, cytokines and cell–cell contact. Many inflammatory genes relevant to the pathogenesis of atherosclerosis are regulated by NF{kappa}B, the activated form of which is present in atherosclerotic plaques. Thus, it is essential to understand the role of this important signaling cascade in atherosclerosis, in a quest for more specific therapeutic targets.

KEYWORDS Atherosclerosis; Thrombosis; Inflammation; NF{kappa}B

Time for primary review 32 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
C. Chen, M. S. Jamaluddin, S. Yan, D. Sheikh-Hamad, and Q. Yao
Human Stanniocalcin-1 Blocks TNF-{alpha}-Induced Monolayer Permeability in Human Coronary Artery Endothelial Cells
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 906 - 912.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.